TFX - Teleflex Incorporated
121.97
| Index: | - | P/E: | 38.44 | EPS (ttm): | 3.17 | Insider Own: | 0.58% | Shs Outstand: | 44.67M | Perf Week: | -2.63% |
| Market Cap: | 5.39B | Forward P/E: | 8.70 | EPS next Y: | 14.02 | Insider Trans: | 0.00% | Shs Float: | 43.93M | Perf Month: | -7.20% |
| Income(ttm): | 149.39M | PEG: | 13.49 | EPS next Q: | 3.36 | Inst Own: | 109.26% | Short Float: | 2.49% | Perf Quarter: | -30.35% |
| Revenue(ttm): | 3.01B | P/S: | 1.79 | EPS this Y: | -4.60% | Inst Trans: | -0.48% | Short Ratio: | 0.91 | Perf Half Y: | -36.52% |
| Book/sh: | 91.67 | P/B: | 1.33 | EPS next Y: | 4.88% | ROA: | 2.04% | Short Interest: | 1.09M | Perf Year: | -43.96% |
| Cash/sh: | 6.43 | P/C: | 18.97 | EPS next 5Y: | 2.85% | ROE: | 3.48% | 52W Range: | 120.06 - 249.90 | Perf YTD: | -31.47% |
| Dividend Est.: | 1.34 (1.10%) | P/FCF: | 11.23 | EPS past 5Y: | -31.49% | ROI: | 2.49% | 52W High: | -51.19% | Beta: | 1.10 |
| Dividend TTM: | 1.36 (1.12%) | Quick Ratio: | 1.32 | Sales past 5Y: | 3.37% | Gross Margin: | 55.87% | 52W Low: | 1.59% | ATR (14): | 4.04 |
| Dividend Ex-Date: | May 20, 2025 | Current Ratio: | 2.28 | EPS Y/Y TTM: | -48.98% | Oper. Margin: | 18.13% | RSI (14): | 39.05 | Volatility: | 2.15% 2.80% |
| Employees: | 14100 | Debt/Eq: | 0.49 | Sales Y/Y TTM: | 0.29% | Profit Margin: | 4.96% | Recom: | 2.75 | Target Price: | 145.25 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.47 | EPS Q/Q: | 541.23% | Payout: | 91.92% | Rel Volume: | 0.33 | Prev Close: | 126.86 |
| Sales Surprise: | 0.19% | EPS Surprise: | 0.89% | Sales Q/Q: | -5.04% | Earnings: | May 01 BMO | Avg Volume: | 1.19M | Price: | 121.97 |
| SMA20: | -4.87% | SMA50: | -7.95% | SMA200: | -34.36% | Undervalued: 19.09% | Volume: | 391,126 | Change: | -3.85% | |
Graham Classic formula value: 40.42
(P/E=8 * 1g) Min value: 30.88
(current P/E * 2g) Max value: 125.65
Average value: 65.65
About Teleflex Incorporated
Teleflex, Inc. engages in the provision of medical technology products. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia, and Original Equipment Manufacturer and Development Services (OEM). The Americas, EMEA, and Asia segments are involved in the design, manufacture, and distribution of medical devices primarily used in critical care and surgical applications and generally serve two end-markets: hospitals and healthcare providers, and home health. The OEM segment refers to the design, manufacture, and supply of devices and instruments for other medical device manufacturers. The company was founded in 1943 and is headquartered in Wayne, PA.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.